These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37782847)

  • 1. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitoring and Time in Range: Association with Adverse Outcomes among People with Type 2 or Gestational Diabetes Mellitus.
    Bitar G; Cornthwaite JA; Sadek S; Ghorayeb T; Daye N; Nazeer S; Ghafir D; Cornthwaite J; Chauhan SP; Sibai BM; Fishel Bartal M
    Am J Perinatol; 2024 May; 41(S 01):e1370-e1377. PubMed ID: 36858069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes.
    Battarbee AN; Sauer SM; Sanusi A; Fulcher I
    Am J Obstet Gynecol; 2024 Jul; 231(1):122.e1-122.e9. PubMed ID: 38527606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.
    Fishel Bartal M; Ashby Cornthwaite JA; Ghafir D; Ward C; Ortiz G; Louis A; Cornthwaite J; Chauhan SSP; Sibai BM
    Am J Perinatol; 2023 Apr; 40(5):461-466. PubMed ID: 35858653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
    McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
    Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
    Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
    J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
    Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
    Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.
    O'Malley G; Ozaslan B; Levy CJ; Castorino K; Desjardins D; Levister C; McCrady-Spitzer S; Church MM; Kaur RJ; Reid C; Kremers WK; Doyle FJ; Trinidad MC; Rosenn B; Pinsker JE; Kudva YC; Dassau E
    Diabetes Technol Ther; 2021 Dec; 23(12):807-817. PubMed ID: 34270347
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring in individuals undergoing gestational diabetes screening.
    Fishel Bartal M; Ashby Cornthwaite J; Ghafir D; Ward C; Nazeer SA; Blackwell SC; Pedroza C; Chauhan SP; Sibai BM
    Am J Obstet Gynecol; 2023 Oct; 229(4):441.e1-441.e14. PubMed ID: 37088275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes.
    Gao V; Snell-Bergeon JK; Malecha E; Johnson CA; Polsky S
    Diabetes Technol Ther; 2024 Aug; 26(8):526-535. PubMed ID: 38386433
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.
    Sotani-Ogawa R; Kusuhara S; Hirota Y; Kim KW; Matsumiya W; Ogawa W; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):449-456. PubMed ID: 37864636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.